Results 241 to 250 of about 1,799,019 (357)

Nanobiocatalysts: Potential Applications in Biofuel Production and Biotransformation

Carbon Neutralization, Volume 5, Issue 3, May 2026.
The application of nanobiocatalysts in the field of biofuel production and the biotransformation of substrate were reviewed. Further, the possible research gaps in the field of biofuel and value‐added compound production and a possible way to enhance the application of nanobiocatalyst in future development are highlighted.
Preethi Muthu, Kalaiselvi Thiyagarajan, V. Pugalenthi, M. Gunasekaran, J. Rajesh Banu   +4 more
wiley   +1 more source

Screening and identification of lactic acid bacteria with α-glucosidase inhibiting activity. [PDF]

Front Microbiol
Liu Y, Yang Z, Liu A, Dong B, Yao Q, Ran X, Zhu D.   +6 more
europepmc   +1 more source

Endogenous Recovery of Fasting C‐Peptide Decreases Progression of Sudomotor Small‐Fibre Dysfunction in Adults With Diabetes: A Real‐World Cohort Study

Diabetes/Metabolism Research and Reviews, Volume 42, Issue 4, May 2026.
ABSTRACT Aims To determine whether recovery of fasting C‐peptide (ΔFCP) reduces deterioration in sudomotor small‐fibre function, whether a threshold exists, and whether associations are complication‐specific. Methods Retrospective real‐world cohort of 288 hospitalised adults with diabetes with repeated fasting C‐peptide and Sudoscan electrochemical ...
Qingyun Cai, Ting Xie, Hongjian Gong, Wenjie Zhang, Lixin Guo, Qi Pan   +5 more
wiley   +1 more source

Design, synthesis, <i>in vitro</i>, and <i>in silico</i> studies on promising α-glucosidase inhibitors based on a quinazolinone-thiophene scaffold. [PDF]

RSC Adv
Baghershahi P, Dastyafteh N, Halimi M, Mohammadi-Khanaposhtani M, Ghafouri SN, Noori M, Ghasemi F, Mojtabavi S, Faramarzi MA, Torabi M, Alikhani M, Larijani B, Javanshir S, Mahdavi M.   +13 more
europepmc   +1 more source

Haemoglobin A1c Time‐In‐Range and Mortality in Adults With Diabetes

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Reduced A1c time in range and particularly greater time below range are associated with increased mortality in adults with diabetes. A1c stability within person‐specific ranges may be a risk predictor for major outcomes in adults with diabetes. ABSTRACT Introduction Glycemic variability over time is a risk factor for diabetes complications.
Paul R. Conlin, Julia C. Prentice, David C. Mohr, Libin Zhang, Donglin Li, Erin Pleasants, Richard E. Nelson, Suma Vupputuri, Gregory A. Nichols   +8 more
wiley   +1 more source

Peptides from 'Vaina Morada' Black Bean Inhibit α-Amylase and α-Glucosidase: A Combined In Silico-In Vitro Study. [PDF]

Foods
Ramirez-Lozano F, Contreras J, Alfaro-Diaz A, Luna-Vital DA, Mathis ACG, Urías-Silvas JE, Mojica L.   +6 more
europepmc   +1 more source

The Effect of Integrated Lifestyle Intervention Incorporating Calorie‐Carbohydrate Restriction With or Without Time‐Restricted Feeding for Remission of Type 2 Diabetes (DIREM): A Single Blind Randomised Controlled Trial

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Diabetes remission is possible through weight loss. Behavioural lifestyle program is effective to achieve diabetes remission. ABSTRACT Aims We conducted the diet and diabetes remission (DIREM) study to assess whether an integrated lifestyle intervention would lead to achieving remission in type 2 diabetes.
Negin Badrooj, Alireza Esteghamati, Kurosh Djafarian, Mir Saeed Yekaninejad, Saba Mohammadpour, Vida Dankoob, Sahar Karimpour Reyhan, Mahsa Abbaszade, Sara Emamgholipour, Sakineh Shab‐Bidar   +9 more
wiley   +1 more source

Rational design and synthesis of new acetamide-indole-benzo[d]imidazole-carboxylic acid hybrids as dual PTP1B/α-glucosidase inhibitors. [PDF]

RSC Adv
Dastyafteh N, Ghafouri SN, Mollazadeh M, Motamedi Shakib N, Halimi M, Hosseini S, Mojtabavi S, Faramarzi MA, Larijani B, Amanlou M, Mohammadi-Khanaposhtani M, Mahdavi M.   +11 more
europepmc   +1 more source

A Multicentre, Prospective, Non‐Interventional Single‐Arm Study Investigating the Impact of Once‐Daily Oral Semaglutide in a Real‐World Adult Population With Type 2 Diabetes in Mexico

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 3, May 2026.
Initiation of oral semaglutide in patients with T2D in routine clinical practice in Mexico significantly reduces HbA1c and weight and improves satisfaction with treatment. ABSTRACT Background To investigate the oral semaglutide use among Mexican adults with type 2 diabetes.
Guillermo González‐Gálvez, Juan C. Garnica‐Cuellar, Miguel Ángel Colín‐García, Aldo Ferreira‐Hermosillo, Silvia A. Jiménez‐Ramos, Aleida Y. Contreras‐Sandoval, Patricia Cruz‐Puente, Manuel Duarte‐Vega   +7 more
wiley   +1 more source

Functional Analysis of Amino Acid Residues Responsible for Substrate Specificity of GH13_17 α‑Glucosidase from <i>Aedes aegypti</i> Saliva (AaMalI). [PDF]

ACS Omega
Auiewiriyanukul W, Saburi W, Mori H, Arthan D, Tharamak S.   +4 more
europepmc   +1 more source